1. Baseline characteristics of participants presenting with or without peripheral artery disease (PAD) Heart Protection Study Group J Vasc Surg 2007;45:645-54

2. Effects of simvastatin allocation on first major coronary event, stroke, or revascularization in participants presenting with or without peripheral artery disease Heart Protection Study Group J Vasc Surg 2007;45:645-54

3. Absolute effects of simvastatin allocation on 5-year rates of first major vascular events among participants subdivided by prior PAD Heart Protection Study Group J Vasc Surg 2007;45:645-54

4. Effects of simvastatin allocation on major vascular events in prior disease subgroups Heart Protection Study Group J Vasc Surg 2007;45:645-54

5. Effects of simvastatin allocation on first major vascular event in participants with or without PAD subdivided by other presenting features Heart Protection Study Group J Vasc Surg 2007;45:645-54

6. Effects of simvastatin allocation on first and all major vascular events in participants with or without PAD Heart Protection Study Group J Vasc Surg 2007;45:645-54

7. Effects of simvastatin allocation on first peripheral vascular event subdivided by presenting features Heart Protection Study Group J Vasc Surg 2007;45:645-54

8. Average use of statin (study or non-study), and average plasma LDL cholesterol concentrations, during follow-up. Table online only Heart Protection Study Group J Vasc Surg 2007;45:645-54

9. DISCUSSION Heart Protection Study Group J Vasc Surg 2007;45:645-54

10. INVITED COMMENTARY William R. Hiatt Heart Protection Study Group J Vasc Surg 2007;45:645-54